Mark Coleman

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.

3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 10, 2026 Axsome Therapeutics Inc. Open-market sale −643 $249.00 $160,107
Jun 8, 2026 Axsome Therapeutics Inc. Option exercise +1,429 — —
Jun 2, 2026 Axsome Therapeutics Inc. Open-market sale −5,537 $223.39 $1,236,910
Jun 1, 2026 Axsome Therapeutics Inc. Open-market sale −6,000 $230.30 $1,381,800
May 29, 2026 Axsome Therapeutics Inc. Open-market sale −6,000 $233.46 $1,400,760
Feb 26, 2026 Axsome Therapeutics Inc. Open-market sale −25,000 $161.11 $4,027,750
Feb 23, 2026 Axsome Therapeutics Inc. Option exercise +6,250 $4.95 $30,938
Feb 20, 2026 Axsome Therapeutics Inc. Option exercise +12,485 $4.95 $61,801
Feb 10, 2026 Axsome Therapeutics Inc. Option exercise +5,193 $8.02 $41,648
Sep 8, 2025 Axsome Therapeutics Inc. Open-market purchase +800 $127.20 $101,760
Sep 8, 2025 Axsome Therapeutics Inc. Open-market purchase +287 $127.30 $36,535
Sep 8, 2025 Axsome Therapeutics Inc. Open-market purchase +488 $127.40 $62,171
May 28, 2025 Axsome Therapeutics Inc. Open-market sale −3,750 $103.43 $387,863
May 27, 2025 Axsome Therapeutics Inc. Open-market sale −3,750 $105.47 $395,513
May 20, 2025 Axsome Therapeutics Inc. Open-market sale −3,000 $107.49 $322,470

Questions about Mark Coleman

What boards is Mark Coleman on?

Mark Coleman sits on the board of Axsome Therapeutics Inc.

How long has Mark Coleman served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.